US Patent Issued to EDITAS MEDICINE on Nov. 4 for "Crispr/CAS-related methods and compositions for treating primary open angle glaucoma" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,231, issued on Nov. 4, was assigned to EDITAS MEDICINE INC. (Cambridge, Mass.).

"Crispr/CAS-related methods and compositions for treating primary open angle glaucoma" was invented by Morgan L. Maeder (Jamaica Plain, Mass.) and David A. Bumcrot (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "CRISPR/CAS-related compositions and methods for treatment of Primary Open Angle Glaucoma (POAG) are disclosed."

The patent was filed on April 1, 2015, under Application No. 15/300,991.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FP...